B. L. Brandt - Concepedia

Author

B. L. Brandt

Walter Reed Army Institute of Research

Also Known As

B Brandt, B L Brandt, B. Brandt, B. L. BRANDT, B. L. Brandt, Bettina Brandt

Publications

1.3K

Citations

H-Index

Concepts

All Affiliations

Walter Reed Army Institute of Research

About

B. L. Brandt is an author at Walter Reed Army Institute of Research specializing in medicine, infection control, and bacterial meningitis.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	14	1.1K
2	Engineering	1	1	36
3	Public Health	1	1	38
4	Allergy	1	1	68
5	Biochemistry	1	1	79

B. L. Brandt

Publications

1.2K

Citations

H-Index

Page 1

	Year	Citations
Immunologic Response of Man to Group B Meningococcal Polysaccharide Vaccines Frederic A. Wyle, Malcolm S. Artenstein, B. L. Brandt, The Journal of Infectious Diseases Microbial PathogensImmunologyB. L. BrandtBacterial PathogensVaccine Target	1972	444
Immune Response of Infants and Children to Disseminated Infections with Neisseria meningitidis J. McLeod Griffiss, B. L. Brandt, Dennis D. Broud, The Journal of Infectious Diseases	1984	89
Expression of the L8 lipopolysaccharide determinant increases the sensitivity of Neisseria meningitidis to serum bactericidal activity Elizabeth Morán, B. L. Brandt, W D Zollinger Infection and Immunity Lps VariantsBactericidal ActivityBacteriologyImmunologyKlebsiella Pneumoniae	1994	79
IgA-dependent, monocyte-mediated, antibacterial activity. George H. Lowell, L F Smith, J. McLeod Griffiss, The Journal of Experimental Medicine Autoimmune DiseaseBacterial MeningitisIgg-dependent ActivityMedicineAntibacterial Activity	1980	76
Antigenic Specificity of Bactericidal Antibodies in Antisera to Neisseria meningitidis Dennis L. Kasper, J L Winkelhake, B. L. Brandt, The Journal of Infectious Diseases VaccinationPolysaccharide AntigenAntibody BindingMedical MicrobiologyAntimicrobial Susceptibility	1973	75
Monoclonal antibodies to serotype 2 and serotype 15 outer membrane proteins of Neisseria meningitidis and their use in serotyping Wendell D. Zollinger, Elizabeth Morán, Holly Connelly, Infection and Immunity Medical MicrobiologyMedicinePathogenesisSerotype SpecificitySerotype 15	1984	72
Serologic Studies of Meningococcal Infection and Polysaccharide Vaccination Malcolm S. Artenstein, B. L. Brandt, Edmund C. Tramont, The Journal of Infectious Diseases VaccinationComplement FixationAllergyImmunologySerologic Testing	1971	68
Safety and immunogenicity of group Y and group W135 meningococcal capsular polysaccharide vaccines in adults J. McLeod Griffiss, B. L. Brandt, Patricia L. Altieri, Infection and Immunity VaccinationVaccine SafetyGroup YVaccine DevelopmentMedicine	1981	44
Response of Children to Neisseria meningitidis Polysaccharide Vaccines Arnold S. Monto, B. L. Brandt, Malcolm S. Artenstein The Journal of Infectious Diseases VaccinationVaccine SafetyVaccine DevelopmentEmerging Infectious DiseasesPediatric Epidemiology	1973	41
Meningococcal serogroup B vaccine protection trial and follow-up studies in Chile. The Chilean National Committee for Meningococcal Disease. Wendell D. Zollinger, J. Boslego, E Morán, PubMed VaccinationVaccine SafetyMedicineMeningococcal DiseaseVaccine Testing	1991	38

Page 1